- Email: [email protected]
Süd-Chemie 2Q 2008: key figures
FOCUS DKR 4059 M, with enzyme sales reaching DKR 3.7 bn. Enzyme sales totalled DKR 1861 M in 2Q 2008, with washing product enzyme sales showing a 13% increase to DKR 627 M (analysts had predicted DKR 589 M) but technical enzymes achieving a growth of only 9% to DKR 588 M (DKR 604 M had been forecast). Enzymes for bioethanol production continued to be the primary growth engine, slightly increasing their share of the N American market. There was a 13% growth in turnover to €453 M for foodstuffs and a 16% growth to €193 M for food enzymes. Novozymes has increased its sales growth forecast for the whole of 2008 from 6-9% to 8-10% and raised its forecast for growth in results from normal operations from 1-4% to 4-6%. Dagbladet Borsen, 14 Aug 2008 (Website: http://www.borsen.dk) (in Danish)
Novozymes sticks with target for enzyme sales: currency rates a potential hazard Novozymes’ leadership is sticking with its plans for developing enzyme sales though it thinks that currency exchange developments could create difficulties. It is thought that a 5% change in the value of the dollar could have an impact of DKR 40-60 M on results from primary operations. Sales of DKR 10 bn by 2010 are thought possible, primarily through organic growth. Investment is continuing into the launch of 6-8 new products in 2008 and emphasis will be maintained on investment in R&D in the enzymes sector as well as the new business areas, referred to as BioBusiness. The allocation of research resources amongst the different product areas will continue to be around 85% for enzymes and 15% for BioBusiness. The company now has around 100 researchers dedicated to the development of enzymes for cellulose-based bioethanol. Dagbladet Borsen, 14 Aug 2008 (Website: http://www.borsen.dk) (in Danish)
Novozymes catalyzing success Novozymes India occupies 65% of the market share in industrial enzymes and plans to increase to 70%, it also holds 90% in textiles and 90% in starch. The company is planning to
OCTOBER 2008
ON
C ATA LY S T S
begin R&D operations in India that spotlight on optimisation of enzyme properties and application development and is investing 13% of its turnover in R&D. The company is planning to manufacture secondgeneration bioethanol from waste and agricultural residues, which will be one of the renewable sources of energy. BioSpectrum, Jul 2008, 6 (7), 62 (Website: http://www.biospectrumindia.com)
Breakthrough for small-scale FT catalysts UK firm Oxford Catalysts has inked a memorandum of understanding for the commercialization of its proprietary catalysts in small size Fischer-Tropsch (FT) processes with an undisclosed technology partner. The FT catalysts, which are claimed to produce tenfold more than traditional catalysts, can make the FT process economically feasible at levels of 500-5000 bbl/day of synthetic fuel. Oxford expects to provide some kilos of catalyst to its partner in 2008, increasing to more than a tonne in 2009, and in commercial volumes after that. Small size FT could be utilized to capture flare gas, permitting the development of medium size stranded gas fields and the generation of sustainable synthetic diesel obtained from organic wastes. TCE (formerly The Chemical Engineer), Aug 2008, (806), 19
PQ & INEOS finalize silica merger INEOS Silicas, a producer of speciality silicas and catalysts in the USA, has merged into PQ Corp, a sodium silicate silica manufacturer in the US. The Carlyle Group, which bought PQ in Jul 2007, will have a 60% stake in the merged company, with the remaining 40% going to INEOS. The merged company has operations in 21 countries and is projected to achieve revenues of $1 bn/y. Industrial Minerals, Aug 2008, (491), 13 & Chemical Engineering World, Jul 2008, 43 (7), 40
Rossari Enzymes an Indian enzyme leader Rossari Enzymes is leading the Indian enzyme market, earning revenues of
Rup 0.82 bn and has emerged successful as the manufacturer of speciality chemicals used for textile processing. The company produces high concentrates and standard formulations of neutral cellulose, acid cellulose, engineered acid cellulose amylases, high temperature stable amylases and catalases. Also, Rossari offers multizyme formulations for bioscouring, wool and silk processing, and print washing. The products are exported to Sri Lanka, Bangladesh, UAE, Australia, Malaysia, Kenya, New Zealand, Jordan, China, Venezuela, and Nepal. So as to meet the customer’s requirements, the company conducts R&D activities for the development of new products. Besides textiles, the company is also engaged in areas like food, feed, leather, and paper industry. Rossari has opened a biotechnology R&D centre at Navi, Mumbai, and has also set-up Rossari Labtech for manufacturing laboratory machines. With the purpose of meeting the growing demand for enzymes, Rossari imports enzymes from US and delivers the formulations to Indian companies. BioSpectrum, Jul 2008, 6 (7), 92 (Website: http://www.biospectrumindia.com)
Süd-Chemie 2Q 2008: key figures For its 1H 2008 (period ends 30 Jun 2008), Süd-Chemie Group has reported sales of €569.7 M (€533.0 M for its 1H 2007), R&D expenditure of €19.1 M (€18.2 M), capital expenditure of €44.9 M (€35.2 M), EBITDA of €75.6 M (€76.1 M), EBIT of €54.1 M (€55.3 M), profit after tax of €24.6 M (€26.2 M), and headcount of 5642 (4881). There is discussion of the business and of the results. Süd-Chemie Interim Report 2Q 2008: Set for Another Record Year, 14 Aug 2008, 2,7,16 (Süd-Chemie AG, Lenbachplatz 6, D-80333 Munich, Germany. Tel: +49 89 51100. Fax: +49 89 5110375. Website: sudchemie.com)
Süd-Chemie 2Q 2008: catalysts division For its 1H 2008 (period ends 30 Jun 2008), the Catalysts Division of SüdChemie Group has reported sales of €218.5 M (€210.5 M for its 1H 2007), EBITDA of €45.5 M (€46.0 M), EBIT of €35.4 M (€35.9 M), capital expenditure (excluding financial investments) of €24.9 M (€17.0 M),
3
Novozymes sticks with target for enzyme sales: currency rates a potential hazard Novozymes’ leadership is sticking with its plans for developing enzyme sales though it thinks that currency exchange developments could create difficulties. It is thought that a 5% change in the value of the dollar could have an impact of DKR 40-60 M on results from primary operations. Sales of DKR 10 bn by 2010 are thought possible, primarily through organic growth. Investment is continuing into the launch of 6-8 new products in 2008 and emphasis will be maintained on investment in R&D in the enzymes sector as well as the new business areas, referred to as BioBusiness. The allocation of research resources amongst the different product areas will continue to be around 85% for enzymes and 15% for BioBusiness. The company now has around 100 researchers dedicated to the development of enzymes for cellulose-based bioethanol. Dagbladet Borsen, 14 Aug 2008 (Website: http://www.borsen.dk) (in Danish)
Novozymes catalyzing success Novozymes India occupies 65% of the market share in industrial enzymes and plans to increase to 70%, it also holds 90% in textiles and 90% in starch. The company is planning to
OCTOBER 2008
ON
C ATA LY S T S
begin R&D operations in India that spotlight on optimisation of enzyme properties and application development and is investing 13% of its turnover in R&D. The company is planning to manufacture secondgeneration bioethanol from waste and agricultural residues, which will be one of the renewable sources of energy. BioSpectrum, Jul 2008, 6 (7), 62 (Website: http://www.biospectrumindia.com)
Breakthrough for small-scale FT catalysts UK firm Oxford Catalysts has inked a memorandum of understanding for the commercialization of its proprietary catalysts in small size Fischer-Tropsch (FT) processes with an undisclosed technology partner. The FT catalysts, which are claimed to produce tenfold more than traditional catalysts, can make the FT process economically feasible at levels of 500-5000 bbl/day of synthetic fuel. Oxford expects to provide some kilos of catalyst to its partner in 2008, increasing to more than a tonne in 2009, and in commercial volumes after that. Small size FT could be utilized to capture flare gas, permitting the development of medium size stranded gas fields and the generation of sustainable synthetic diesel obtained from organic wastes. TCE (formerly The Chemical Engineer), Aug 2008, (806), 19
PQ & INEOS finalize silica merger INEOS Silicas, a producer of speciality silicas and catalysts in the USA, has merged into PQ Corp, a sodium silicate silica manufacturer in the US. The Carlyle Group, which bought PQ in Jul 2007, will have a 60% stake in the merged company, with the remaining 40% going to INEOS. The merged company has operations in 21 countries and is projected to achieve revenues of $1 bn/y. Industrial Minerals, Aug 2008, (491), 13 & Chemical Engineering World, Jul 2008, 43 (7), 40
Rossari Enzymes an Indian enzyme leader Rossari Enzymes is leading the Indian enzyme market, earning revenues of
Rup 0.82 bn and has emerged successful as the manufacturer of speciality chemicals used for textile processing. The company produces high concentrates and standard formulations of neutral cellulose, acid cellulose, engineered acid cellulose amylases, high temperature stable amylases and catalases. Also, Rossari offers multizyme formulations for bioscouring, wool and silk processing, and print washing. The products are exported to Sri Lanka, Bangladesh, UAE, Australia, Malaysia, Kenya, New Zealand, Jordan, China, Venezuela, and Nepal. So as to meet the customer’s requirements, the company conducts R&D activities for the development of new products. Besides textiles, the company is also engaged in areas like food, feed, leather, and paper industry. Rossari has opened a biotechnology R&D centre at Navi, Mumbai, and has also set-up Rossari Labtech for manufacturing laboratory machines. With the purpose of meeting the growing demand for enzymes, Rossari imports enzymes from US and delivers the formulations to Indian companies. BioSpectrum, Jul 2008, 6 (7), 92 (Website: http://www.biospectrumindia.com)
Süd-Chemie 2Q 2008: key figures For its 1H 2008 (period ends 30 Jun 2008), Süd-Chemie Group has reported sales of €569.7 M (€533.0 M for its 1H 2007), R&D expenditure of €19.1 M (€18.2 M), capital expenditure of €44.9 M (€35.2 M), EBITDA of €75.6 M (€76.1 M), EBIT of €54.1 M (€55.3 M), profit after tax of €24.6 M (€26.2 M), and headcount of 5642 (4881). There is discussion of the business and of the results. Süd-Chemie Interim Report 2Q 2008: Set for Another Record Year, 14 Aug 2008, 2,7,16 (Süd-Chemie AG, Lenbachplatz 6, D-80333 Munich, Germany. Tel: +49 89 51100. Fax: +49 89 5110375. Website: sudchemie.com)
Süd-Chemie 2Q 2008: catalysts division For its 1H 2008 (period ends 30 Jun 2008), the Catalysts Division of SüdChemie Group has reported sales of €218.5 M (€210.5 M for its 1H 2007), EBITDA of €45.5 M (€46.0 M), EBIT of €35.4 M (€35.9 M), capital expenditure (excluding financial investments) of €24.9 M (€17.0 M),
3